The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Today’s cough syrup could turn into tomorrow’s treatment for Parkinson’s disease. Recent research in the U.K. is the latest to suggest that a common ingredient in cough syrup, ambroxol, might be able ...

Read about the latest research in nutrition. Answers to questions about nutrition, body weight, herbal and nutritional supplements, and the role of diet in improving and maintaining your health.

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk ...

Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia but did not show an effect on cognition compared with placebo, a year ...

ABOUT Arielle Domb is a journalist based in London who investigates health, sex and subculture. Her work has appeared in The New York Times, The Guardian, VICE, Vogue, Cosmopolitan and more.

“We hope that Ambroxol, or drugs like Ambroxol, will be able to prevent the onset of Parkinson's disease and dementia if it is given early enough,” Dr Stephen Pasternak told The Standard.

Medindia has been a pioneer in many ways and was one of the earliest health websites to be launched from India. Medindia was founded by Dr. Sunil Shroff, Arun Shroff and Sanjay Shroff - three ...

A cough medicine used for decades in Europe called ambroxol has shown promise for treating dementia in people with Parkinson's disease. The corresponding study was published in JAMA Neurology. People ...